* FDA says journal reprint is misleading * Materials overstated Taxotere's benefits -FDA * Sanofi: materials appropriate, working with FDA (Adds company comment, paragraphs 6-7) WASHINGTON, May 13 - U.S. health regulators have cited Sanofi-Aventis...
BOSTON, Feb 4 - More is not always better when it comes to...
LONDON, Sept 12 - GlaxoSmithKline Plc is creating a new cancer-focused research and development group, marking a realignment of its R&D machine, the world's second largest drugmaker said on Friday. New Chief Executive Andrew Witty,...
* Companies say drug deemed ineffective in Phase III study * Studies of aflibercept continue vs other cancer types * Regeneron stock down about 5 pct (Adds details on failed study, studies that continue) NEW...
* Say drug deemed ineffective in Phase III study * Studies of drug continue vs other cancer types NEW YORK, Sept 11 - Sanofi-Aventis and Regeneron Pharmaceuticals on Friday said they had halted a late-stage...
* Nymox headline cites "Major effect on liver cancer" * Nymox release notes results seen in rodents * Shares sharply higher (Adds analyst criticism of press release, updates shares) NEW YORK, Aug 26 - Nymox...
FRANKFURT, Aug 19 - German drugmaker Bayer has suffered defeat in an Indian court in a crucial legal dispute over approval of a copycat version of its cancer drug Nexavar. Bayer had taken India's Cipla...
* TNF blocker drugs to carry stronger warnings * Cancer risk occurs about 30 months after treatment-FDA (Adds FDA and company comments, background) WASHINGTON, Aug 4 - Blockbuster prescription drugs used to treat rheumatoid arthritis...
* TNF blocker drugs to carry stronger warnings * Cancer risk occurs about 30 months after treatment * FDA says agency, companies working to understand risk WASHINGTON, Aug 4 - Prescription drugs used to treat...
* U.S. study finds statin use linked with lower cancer risk * Statins also associated with other urological benefits * Findings preliminary, further clinical trials needed LONDON, April 26 - Cholesterol-lowering statin drugs may protect...